An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)

• Status: Completed
• Trial end date: 2002-12-06
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to evaluate the pain relieving effect and safety of an investigational drug in women with moderate to severe primary dysmenorrhea (painful menstruation).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Etoricoxib; Naproxen

Criteria

Inclusion Criteria:

• Women 18 years of age or older suffering from painful menstruation

Exclusion Criteria:

• Women taking medications that are not allowed in the study (such as pain medications, antidepressants, tranquilizers, hypnotics, sedatives, or oral contraceptives).

• Women who are pregnant, breast-feeding or within 6 weeks of giving birth